FDAMayo Clinic Cancer RegistryReferencesstage IIB/C melanomaPembrolizumabstage IIB/IIC melanomaadjuvant immunotherapy
…B/IIC patients were identified from 2018-2022 in NCDB. Prior to FDA approval, 366/5989(6.1%) with stage IIB and 269/3363(8.0%) with…